187 related articles for article (PubMed ID: 23052618)
21. Identification of a novel de novo GATA3 mutation in a patient with HDR syndrome.
Chen L; Chen B; Leng W; Lui X; Wu Q; Ouyang X; Liang Z
J Int Med Res; 2015 Oct; 43(5):718-24. PubMed ID: 26268891
[TBL] [Abstract][Full Text] [Related]
22. Clinical and molecular characteristics of two Italian kindreds with hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome.
Dinoi E; Pierotti L; Mazoni L; Citro F; Della Valentina S; Sardella C; Borsari S; Michelucci A; Caligo MA; Marcocci C; Cetani F
J Endocrinol Invest; 2024 Feb; 47(2):469-478. PubMed ID: 37561279
[TBL] [Abstract][Full Text] [Related]
23. A Novel
Chu XY; Li YP; Nie M; Wang O; Jiang Y; Li M; Xia WB; Xing XP
Chin Med J (Engl); 2017 Jun; 130(11):1378-1380. PubMed ID: 28524840
[No Abstract] [Full Text] [Related]
24. A Case of HDR Syndrome and Ichthyosis: Dual Diagnosis by Whole-Genome Sequencing of Novel Mutations in GATA3 and STS Genes.
Goodwin G; Hawley PP; Miller DT
J Clin Endocrinol Metab; 2016 Mar; 101(3):837-40. PubMed ID: 26731259
[TBL] [Abstract][Full Text] [Related]
25. The syndrome of hypoparathyroidism, deafness, and renal anomalies.
Upadhyay J; Steenkamp DW; Milunsky JM
Endocr Pract; 2013; 19(6):1035-42. PubMed ID: 23757620
[TBL] [Abstract][Full Text] [Related]
26. Novel heterozygous GATA3 and SLC34A3 variants in a 6-year-old boy with Barakat syndrome and hypercalciuria.
Yu S; Chen WX; Lu W; Chen C; Ni Y; Duan B; Wang B; Wang H; Xu ZM
Mol Genet Genomic Med; 2020 May; 8(5):e1222. PubMed ID: 32155322
[TBL] [Abstract][Full Text] [Related]
27. Novel DNA mutation in the GATA3 gene in an Emirati boy with HDR syndrome and hypomagnesemia.
Al-Shibli A; Al Attrach I; Willems PJ
Pediatr Nephrol; 2011 Jul; 26(7):1167-70. PubMed ID: 21399899
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel GATA3 mutation in a deaf Taiwanese family by massively parallel sequencing.
Lin YH; Wu CC; Hsu TY; Chiu WY; Hsu CJ; Chen PL
Mutat Res; 2015 Jan; 771():1-5. PubMed ID: 25771973
[TBL] [Abstract][Full Text] [Related]
29. The Syndrome of Familial Hypoparathyroidism, Sensorineural Deafness and Renal Dysplasia.
Meena RL; Maloo SK; Samar N; Ruhela A; Saini S
J Assoc Physicians India; 2015 Jun; 63(6):73-5. PubMed ID: 26710407
[TBL] [Abstract][Full Text] [Related]
30. 10p12.1 deletion: HDR phenotype without DGS2 features.
Benetti E; Murer L; Bordugo A; Andreetta B; Artifoni L
Exp Mol Pathol; 2009 Feb; 86(1):74-6. PubMed ID: 19022243
[TBL] [Abstract][Full Text] [Related]
31. HDR syndrome, detected in the neonatal period by newborn hearing screening.
Takai S; Adachi M; Takahashi H; Shirakura M; Honkura Y; Yamauchi D; Katori Y
Auris Nasus Larynx; 2024 Apr; 51(2):406-410. PubMed ID: 37640596
[TBL] [Abstract][Full Text] [Related]
32. A novel mutation in the GATA3 gene in a family with HDR syndrome (Hypoparathyroidism, sensorineural Deafness and Renal anomaly syndrome).
Adachi M; Tachibana K; Asakura Y; Tsuchiya T
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):87-92. PubMed ID: 16509533
[TBL] [Abstract][Full Text] [Related]
33. Audiometric characteristics of a dutch family with a new mutation in GATA3 causing HDR syndrome.
van Beelen E; Leijendeckers JM; Admiraal RJ; Huygen PL; Hoefsloot LH; Pennings RJ; Snik AF; Kunst HP
Audiol Neurootol; 2014; 19(2):106-14. PubMed ID: 24434941
[TBL] [Abstract][Full Text] [Related]
34. Transcription factor GATA3 and the human HDR syndrome.
Van Esch H; Devriendt K
Cell Mol Life Sci; 2001 Aug; 58(9):1296-300. PubMed ID: 11577985
[TBL] [Abstract][Full Text] [Related]
35. [HDR syndrome (GATA3 haploinsufficiency syndrome)].
Mochizuki T; Fujita K; Yamada H; Ogata T
Nihon Rinsho; 2006 Jun; Suppl 2():74-6. PubMed ID: 16817354
[No Abstract] [Full Text] [Related]
36. Vitamin D deficiency in a patient with HDR syndrome.
Kostoglou-Athanassiou I; Stefanopoulos D; Karfi A; Athanassiou P
BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26156834
[TBL] [Abstract][Full Text] [Related]
37. GATA3 abnormalities in six patients with HDR syndrome.
Fukami M; Muroya K; Miyake T; Iso M; Kato F; Yokoi H; Suzuki Y; Tsubouchi K; Nakagomi Y; Kikuchi N; Horikawa R; Ogata T
Endocr J; 2011; 58(2):117-21. PubMed ID: 21242646
[TBL] [Abstract][Full Text] [Related]
38. Synergistic role of retinoic acid signaling and Gata3 during primitive choanae formation.
Kurosaka H; Mushiake J; Saha M; Wu Y; Wang Q; Kikuchi M; Nakaya A; Yamamoto S; Inubushi T; Koga S; Sandell LL; Trainor PA; Yamashiro T
Hum Mol Genet; 2021 Nov; 30(24):2383-2392. PubMed ID: 34272563
[TBL] [Abstract][Full Text] [Related]
39. Novel dominant-negative mutant of GATA3 in HDR syndrome.
Ohta M; Eguchi-Ishimae M; Ohshima M; Iwabuki H; Takemoto K; Murao K; Chisaka T; Yamamoto E; Higaki T; Isoyama K; Eguchi M; Ishii E
J Mol Med (Berl); 2011 Jan; 89(1):43-50. PubMed ID: 21120445
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor.
Ali A; Christie PT; Grigorieva IV; Harding B; Van Esch H; Ahmed SF; Bitner-Glindzicz M; Blind E; Bloch C; Christin P; Clayton P; Gecz J; Gilbert-Dussardier B; Guillen-Navarro E; Hackett A; Halac I; Hendy GN; Lalloo F; Mache CJ; Mughal Z; Ong AC; Rinat C; Shaw N; Smithson SF; Tolmie J; Weill J; Nesbit MA; Thakker RV
Hum Mol Genet; 2007 Feb; 16(3):265-75. PubMed ID: 17210674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
